BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27537504)

  • 1. Molecular Models of STAT5A Tetramers Complexed to DNA Predict Relative Genome-Wide Frequencies of the Spacing between the Two Dimer Binding Motifs of the Tetramer Binding Sites.
    Sathyanarayana BK; Li P; Lin JX; Leonard WJ; Lee B
    PLoS One; 2016; 11(8):e0160339. PubMed ID: 27537504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.
    Soldaini E; John S; Moro S; Bollenbacher J; Schindler U; Leonard WJ
    Mol Cell Biol; 2000 Jan; 20(1):389-401. PubMed ID: 10594041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function.
    Lin JX; Li P; Liu D; Jin HT; He J; Ata Ur Rasheed M; Rochman Y; Wang L; Cui K; Liu C; Kelsall BL; Ahmed R; Leonard WJ
    Immunity; 2012 Apr; 36(4):586-99. PubMed ID: 22520852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat5 tetramer formation is associated with leukemogenesis.
    Moriggl R; Sexl V; Kenner L; Duntsch C; Stangl K; Gingras S; Hoffmeyer A; Bauer A; Piekorz R; Wang D; Bunting KD; Wagner EF; Sonneck K; Valent P; Ihle JN; Beug H
    Cancer Cell; 2005 Jan; 7(1):87-99. PubMed ID: 15652752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How p53 binds DNA as a tetramer.
    McLure KG; Lee PW
    EMBO J; 1998 Jun; 17(12):3342-50. PubMed ID: 9628871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the unphosphorylated STAT5a dimer.
    Neculai D; Neculai AM; Verrier S; Straub K; Klumpp K; Pfitzner E; Becker S
    J Biol Chem; 2005 Dec; 280(49):40782-7. PubMed ID: 16192273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells.
    Hou Z; Srivastava S; Mistry MJ; Herbst MP; Bailey JP; Horseman ND
    Mol Endocrinol; 2003 Oct; 17(10):1910-20. PubMed ID: 12869589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
    Silva CM; Lu H; Day RN
    Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
    Chakraborty A; Dyer KF; Tweardy DJ
    Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P22 Arc repressor: role of cooperativity in repression and binding to operators with altered half-site spacing.
    Smith TL; Sauer RT
    J Mol Biol; 1995 Jun; 249(4):729-42. PubMed ID: 7602585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity.
    Peng B; Sutherland KD; Sum EY; Olayioye M; Wittlin S; Tang TK; Lindeman GJ; Visvader JE
    Mol Endocrinol; 2002 Sep; 16(9):2019-33. PubMed ID: 12198240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive nuclear import of latent and activated STAT5a by its coiled coil domain.
    Iyer J; Reich NC
    FASEB J; 2008 Feb; 22(2):391-400. PubMed ID: 17846080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction.
    Fahrenkamp D; de Leur HS; Küster A; Chatain N; Müller-Newen G
    Cell Commun Signal; 2015 Feb; 13():10. PubMed ID: 25885255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-terminal domain dimer interface mutant 434 repressors have altered dimerization and DNA binding specificities.
    Donner AL; Paa K; Koudelka GB
    J Mol Biol; 1998 Nov; 283(5):931-46. PubMed ID: 9799634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression.
    Zhang Q; Wang HY; Liu X; Wasik MA
    Nat Med; 2007 Nov; 13(11):1341-8. PubMed ID: 17922009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association states of the transcription activator protein NtrC from E. coli determined by analytical ultracentrifugation.
    Rippe K; Mücke N; Schulz A
    J Mol Biol; 1998 May; 278(5):915-33. PubMed ID: 9600853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-operative binding of Escherichia coli SSB tetramers to single-stranded DNA in the (SSB)35 binding mode.
    Ferrari ME; Bujalowski W; Lohman TM
    J Mol Biol; 1994 Feb; 236(1):106-23. PubMed ID: 8107097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA-binding capacity of genetic variants of the bovine STAT5A transcription factor.
    Flisikowski K; Szymanowska M; Zwierzchowski L
    Cell Mol Biol Lett; 2003; 8(3):831-40. PubMed ID: 12949622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation.
    Liu X; Robinson GW; Hennighausen L
    Mol Endocrinol; 1996 Dec; 10(12):1496-506. PubMed ID: 8961260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of an engineered Cro monomer bound nonspecifically to DNA: possible implications for nonspecific binding by the wild-type protein.
    Albright RA; Mossing MC; Matthews BW
    Protein Sci; 1998 Jul; 7(7):1485-94. PubMed ID: 9684880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.